Campbell & Co Investment Adviser’s Sabra Healthcare REIT SBRA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-28,276	Closed	-$544K	–	1325
2026 Q1	$544K	Sell	28,276 -164	-0.6%	-$3.23K	0.03%	715
2025 Q4	$539K	Sell	28,440 -34,975	-55%	-$648K	0.03%	798
2025 Q3	$1.18M	Sell	63,415 -20,313	-24%	-$379K	0.09%	350
2025 Q2	$1.54M	Sell	83,728 -8,208	-9%	-$146K	0.1%	327
2025 Q1	$1.61M	Buy	91,936 +68,246	+288%	+$1.15M	0.12%	258
2024 Q4	$410K	Buy	+23,690	New	+$433K	0.03%	732
2023 Q4	–	Sell	-12,719	Closed	-$177K	–	1312
2023 Q3	$177K	Buy	+12,719	New	+$163K	0.02%	863

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Campbell & Co Investment Adviser's SBRA Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 28,276 shares — an estimated $544K sold.

Campbell & Co Investment Adviser first reported a position in SBRA in Q3 2023 and held it in 7 quarters. The position peaked at $1.61M in Q1 2025. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Campbell & Co Investment Adviser reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
Campbell & Co Investment Adviser sold 28,276 Sabra Healthcare REIT shares in Q2 2026, an estimated $544K.
Campbell & Co Investment Adviser first reported a position in Sabra Healthcare REIT in Q3 2023 and held it in 7 quarters.
Campbell & Co Investment Adviser's Sabra Healthcare REIT position peaked at $1.61M in Q1 2025.
466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.